<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04612595</url>
  </required_header>
  <id_info>
    <org_study_id>WJWang002</org_study_id>
    <nct_id>NCT04612595</nct_id>
  </id_info>
  <brief_title>The Association Between sUCR and the Survival in Patients With DKD</brief_title>
  <official_title>The Association Between Serum Urea Nitrogen to Creatinine Ratio and the Survival in Patients With DKD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangdong Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangdong Provincial People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Research Objective: To evaluate the prognostic value of serum urea nitrogen to creatinine&#xD;
      ratio (sUCR) in the progression of DKD.&#xD;
&#xD;
      Research Design: This study was designed as a multicenter, retrospective cohort study.&#xD;
      According to sex and CKD stage , patients are divided into four groups,then evaluate the&#xD;
      prognostic value of mean sUCR and ΔsUCR (fluctuation of sUCR over time, meaning monthly rate&#xD;
      of change) in the progression of DKD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Object and source: Patients diagnosed with DKD who meet the inclusion criteria are enrolled&#xD;
      into the study.&#xD;
&#xD;
      Observation index: At baseline and every medical visit, therapeutic relevant information was&#xD;
      collected. Data mainly include demographic characteristics(age, gender, place of residence,&#xD;
      marriage, education degree), lifestyles(smoking, drinking, exercise), clinical&#xD;
      characteristics(body mass index, blood pressure, duration , history of CVD, complications,&#xD;
      nutrition situation), laboratory indexes (serum creatinine, blood urea nitrogen, glycosylated&#xD;
      hemoglobin, urinary albumin to creatinine ratio, 24-hour urinary albumin, 24-hour urine urea&#xD;
      nitrogen, etc.).&#xD;
&#xD;
      Quality assurance plan: The present study should be performed according to the principles of&#xD;
      the Declaration of Helsinki and has been approved by the Ethics Committee of Guangdong&#xD;
      Provincial People's Hospital.&#xD;
&#xD;
      Plan for missing data: When the participants drop out, the researcher should contact the&#xD;
      participants by phone, email, text message, letter etc. and ask the reason, making record as&#xD;
      full as possible.&#xD;
&#xD;
      Statistical analysis plan: Data are presented as mean±SD for continuous variables and as a&#xD;
      number(percentage) for categorical variables. According to sex and CKD stage , patients are&#xD;
      divided into four groups,then evaluate the prognostic value of mean sUCR and ΔsUCR&#xD;
      (fluctuation of sUCR over time, meaning monthly rate of change) in the progression of DKD.&#xD;
      The relationship between baseline characteristics among the four groups was compared by using&#xD;
      one-way analysis of variance test, Kruskal-Wallis test or Chi-squared test where appropriate.&#xD;
      Survival rates are estimated using Kaplan-Meier analysis, and the significance of differences&#xD;
      was analyzed using the log-rank test. Cox proportional hazard regression analysis is used to&#xD;
      assess the association between the clinical outcomes and mean sUCR and ΔsUCR. In multivariate&#xD;
      analysis, we enter variables using a P value of &lt;0.10 as the selection criterion or&#xD;
      considered clinically significant. Hazard ratios (HRs) are presented with 95% CIs. All&#xD;
      statistical analysis was performed with the use of SPSS (version 19.0, SPSS, Chicago, USA)&#xD;
      and Prism 7.0 (GraphPad Software, San Diego, CA, USA). A two-tailed P value &lt;0.05 was&#xD;
      considered to be statistically significant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>all-cause death</measure>
    <time_frame>10 years</time_frame>
    <description>according to the criteria of death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>a composite of end-stage kidney disease</measure>
    <time_frame>10 years</time_frame>
    <description>dialysis, transplantation, or a sustained estimated GFR of &lt;15 ml per minute per 1.73 m2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>increasing by 50% of the serum creatinine level from baseline</measure>
    <time_frame>10 years</time_frame>
    <description>increasing by 50% of the serum creatinine level from baseline</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Diabetic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <description>Group A are males with CKD stage 1-2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <description>Group B are males with CKD stage 3-4.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <description>Group C are females with CKD stage 1-2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group D</arm_group_label>
    <description>Group D are females with CKD stage 3-4.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>serum urea nitrogen to creatinine ratio</intervention_name>
    <description>According to sex and CKD stage , patients are divided into four groups,then evaluate whether the different mean sUCR and ΔsUCR can influent the survival of DKD patients.</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_label>Group D</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        DKD was defined as those diagnosed by pathological biopsy, or those with eGFR &lt;60 ml/min&#xD;
        per 1.73 m2, or presence of clinically detectable albuminuria over 3 months which is caused&#xD;
        by diabetes.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Patients were diagnosed with DKD, and CKD stages 1-4.&#xD;
&#xD;
               -  Patients' age was between 18-70 years old. ③Clinical datum were complete.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
        ①Patients were combined with other type of kidney disease; ②Pregnancy women; ③Infection;&#xD;
        ④Severe liver disease; ⑤ malignant tumor;⑥Acute heart failure; ⑦Acute cardiovascular and&#xD;
        cerebrovascular diseases ⑧gastrointestinal hemorrhage.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wenjian Wang, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Guangdong Provincial People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wenjian Wang, PhD</last_name>
    <phone>0086-020-83827812-61421</phone>
    <email>wwjph@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guangdong Provincial People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenjian Wang, PhD</last_name>
      <phone>0086-020-83827812-61421</phone>
      <email>wwjph@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, Li Y, Zhao Z, Qin X, Jin D, Zhou M, Tang X, Hu Y, Wang L. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. 2017 Jun 27;317(24):2515-2523. doi: 10.1001/jama.2017.7596.</citation>
    <PMID>28655017</PMID>
  </reference>
  <reference>
    <citation>Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z, Li Y, Yeung RO, Wang J, Matsushita K, Coresh J, Zhao MH, Wang H. Trends in Chronic Kidney Disease in China. N Engl J Med. 2016 Sep 1;375(9):905-6. doi: 10.1056/NEJMc1602469.</citation>
    <PMID>27579659</PMID>
  </reference>
  <reference>
    <citation>Kitada M, Ogura Y, Monno I, Koya D. A Low-Protein Diet for Diabetic Kidney Disease: Its Effect and Molecular Mechanism, an Approach from Animal Studies. Nutrients. 2018 Apr 27;10(5). pii: E544. doi: 10.3390/nu10050544. Review.</citation>
    <PMID>29702558</PMID>
  </reference>
  <reference>
    <citation>Metzger M, Yuan WL, Haymann JP, Flamant M, Houillier P, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Bankir L, Fouque D, Stengel B. Association of a Low-Protein Diet With Slower Progression of CKD. Kidney Int Rep. 2017 Aug 30;3(1):105-114. doi: 10.1016/j.ekir.2017.08.010. eCollection 2018 Jan.</citation>
    <PMID>29340320</PMID>
  </reference>
  <reference>
    <citation>Song M, Fung TT, Hu FB, Willett WC, Longo VD, Chan AT, Giovannucci EL. Association of Animal and Plant Protein Intake With All-Cause and Cause-Specific Mortality. JAMA Intern Med. 2016 Oct 1;176(10):1453-1463. doi: 10.1001/jamainternmed.2016.4182. Erratum in: JAMA Intern Med. 2016 Nov 1;176(11):1728.</citation>
    <PMID>27479196</PMID>
  </reference>
  <reference>
    <citation>Bross R, Noori N, Kovesdy CP, Murali SB, Benner D, Block G, Kopple JD, Kalantar-Zadeh K. Dietary assessment of individuals with chronic kidney disease. Semin Dial. 2010 Jul-Aug;23(4):359-64. doi: 10.1111/j.1525-139X.2010.00743.x. Epub 2010 Jul 29. Review.</citation>
    <PMID>20673254</PMID>
  </reference>
  <reference>
    <citation>Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int. 1985 Jan;27(1):58-65.</citation>
    <PMID>3981873</PMID>
  </reference>
  <reference>
    <citation>Kopple JD, Coburn JW. Evaluation of chronic uremia. Importance of serum urea nitrogen, serum creatinine, and their ratio. JAMA. 1974 Jan 7;227(1):41-4.</citation>
    <PMID>4859625</PMID>
  </reference>
  <reference>
    <citation>Inaguma D, Koide S, Ito E, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y; AICOPP group. Ratio of blood urea nitrogen to serum creatinine at initiation of dialysis is associated with mortality: a multicenter prospective cohort study. Clin Exp Nephrol. 2018 Apr;22(2):353-364. doi: 10.1007/s10157-017-1458-x. Epub 2017 Aug 1.</citation>
    <PMID>28766029</PMID>
  </reference>
  <reference>
    <citation>American Diabetes Association. 10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S105-S118. doi: 10.2337/dc18-S010. Review.</citation>
    <PMID>29222381</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>June 15, 2020</study_first_submitted>
  <study_first_submitted_qc>November 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2020</study_first_posted>
  <last_update_submitted>November 2, 2020</last_update_submitted>
  <last_update_submitted_qc>November 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>serum urea nitrogen to creatinine ratio</keyword>
  <keyword>diabetic kidney disease</keyword>
  <keyword>survival</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Diabetic Nephropathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 1, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/95/NCT04612595/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

